Latest Feature

Big data and personalized medicine: Q&A with Definiens CEO Thomas Heydler

Definiens CEO Thomas Heydler discusses his ambition to position his company at the forefront of the coming revolution in personalized and predictive medicines.

The making of an icon | Dr. Tom Fogarty's obsession with innovation

Medtech icon Dr. Tom Fogarty tells MassDevice.com about his unconventional path from upstart tinkerer in the suburbs of Cincinnati to healthcare celebrity in the heart of Silicon Valley, in Part 1 of a 3-part series.

DNA analysis in your pocket - Q&A with QuantuMDx founder Jonathan O'Halloran

QuantuMDx envisions a future where laboratory-quality diagnostics are mobile, cheap and available to everyone, from healthcare providers in developing countries to parents dealing with ill children.

Medical device tax: At least $510B paid in 2013

A MassDevice.com analysis of reported payments for the medical device tax last year finds that 14 companies accounted for more than 97% of the nearly $500 million collected.

Breathing easier with SinuSys | MassDevice Q&A

SinuSys CEO Thomas Schreck and CMO Dr. Jerome Hester tell MassDevice.com how they hope to replace sinus surgery with a simple, in-office procedure and how a doctor and his patient formed a company together.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

IPO: Stent graft maker Trivascular Tech. jumps on opening day

April 16, 2014 by Arezu Sarvestani

Trivascular Technologies prices its initial public offering below range at $12 per share, with the stock gaining 15% in its first day.

Stent graft maker Trivascular Tech. jumps on opening day of IPO

Trivascular Technologies (NSDQ:TRIV) shares made a good showing on their first day on the Nasdaq stock exchange, having gained 15% by about 4 p.m. EST.

MassDevice.com +3 | The top 3 medtech stories for Apr. 16, 2014

April 16, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Urologix completes layoffs, announces preliminary results

April 16, 2014 by Arezu Sarvestani

Minnesota medical device maker Urologix completes the previously announced restructuring of its sales team as the company prepares to release its 3rd quarter earnings.

Urologix completes layoffs, announces preliminary results

Embattled ConMed surges on reports of potential sale

April 16, 2014 by Arezu Sarvestani

Wall Street rallies for ConMed amid reports that the surgical devices maker is on the auction block after weeks of fighting a nasty 3-way proxy war.

ConMed surges on reports of potential sale

Surgical devices maker ConMed (NSDQ:CNMD) got a little Wall Street love after news sources reported today that the company may be up for sale.

Abbott's earnings take a beating in Q1

April 16, 2014 by Arezu Sarvestani

Abbott Labs' earnings sink more than 30% in its 1st quarter of 2014 as special charges eat up its bottom line.

Abbott's earnings take a beating in Q1

Illinois-based Abbott (NYSE:ABT) managed to beat analysts' expectations for its 1st quarter, even as sales waned and special charges eroded its bottom line.

St. Jude Medical beats The Street, loses points anyway

April 16, 2014 by Arezu Sarvestani

St. Jude Medical meets Wall Street's expectations for its 1st quarter of 2014 with moderate sales growth across its product lines, but shares take a downward turn in morning trading.

St. Jude Medical meets The Street, loses points anyway

Minnesota medtech titan St. Jude Medical (NYSE:STJ) lost a few points on Wall Street today after posting 1st quarter earnings a penny above analysts' consensus estimate.

CeQur names medtech veteran as new CEO | Medtech personnel moves for the week of Apr. 14, 2014

April 16, 2014 by MassDevice

Here's a look at some of the top personnel stories for medical device companies this week.

CeQur gets new CEO from Becton Dickinson | Personnel Moves

April 11, 2014 by Arezu Sarvestani

fired/hired

Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp